Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
fludarabine (fludara) (1 trial)
in vitro-treated bone marrow (1 trial)
methylprednisolone (medrol) (1 trial)
sargramostim (leukine) (1 trial)
tacrolimus (prograf) (1 trial)
Graft vs Host Disease (Phase 3)
Leukemia (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Preleukemia (Phase 3)
Syndrome (Phase 3)
Trials (1 total)
Trial APIs (8 total)